G. Horst

发表

Prevalence and characterization of neutrophil cytoplasmic antibodies in autoimmune liver diseases

C. Kallenberg, P. Limburg, J. Kleibeuker, 1993, Hepatology.

Detection of autoantibodies against myeloid lysosomal enzymes: a useful adjunct to classification of patients with biopsy-proven necrotizing arteritis.

C. Kallenberg, P. Limburg, T. The, 1991, The American journal of medicine.

High mobility group box 1 skews macrophage polarization and negatively influences phagocytosis of apoptotic cells.

P. Limburg, M. Bijl, J. Westra, 2016, Rheumatology.

Opsonization of late apoptotic cells by systemic lupus erythematosus (SLE) autoantibodies inhibits their uptake via an Fc gamma R-dependent mechanism

C. Kallenberg, E. Reefman, P. Limburg, 2007 .

Opsonization of late apoptotic cells by systemic lupus erythematosus autoantibodies inhibits their uptake via an Fcgamma receptor-dependent mechanism.

C. Kallenberg, E. Reefman, P. Limburg, 2007, Arthritis and rheumatism.

Serum markers associated with disease activity in giant cell arteritis and polymyalgia rheumatica.

A. Boots, E. Brouwer, S. Arends, 2015, Rheumatology.

Disturbed B Cell Homeostasis in Newly Diagnosed Giant Cell Arteritis and Polymyalgia Rheumatica

P. Kluin, A. Boots, E. Brouwer, 2014, Arthritis & rheumatology.

Aging disturbs the balance between effector and regulatory CD4+ T cells

B. Kroesen, A. Boots, S. Tete, 2014, Experimental Gerontology.

Measurement of increases in anti-double-stranded DNA antibody levels as a predictor of disease exacerbation in systemic lupus erythematosus. A long-term, prospective study.

P. Limburg, C. Kallenberg, G. Horst, 1990, Arthritis and rheumatism.

Changes in levels of antibodies against the 70 kDa and a polypeptides of the U1RNP complex in relation to exacerbations of systemic lupus erythematosus.

W. V. van Venrooij, P. Limburg, C. Kallenberg, 1991, The Journal of rheumatology.

Changes in plasma levels of interleukin‐2 receptor in relation to disease exacerbations and levels of anti‐dsDNA and complement in systemic lupus erythematosus

P. Limburg, C. Kallenberg, G. Horst, 1990, Clinical and experimental immunology.

Rises in anti-double stranded DNA antibody levels prior to exacerbations of systemic lupus erythematosus are not merely due to polyclonal B cell activation.

C. Kallenberg, P. Limburg, C. Kallenberg, 1991, Clinical immunology and immunopathology.

Treatment with Anti-HMGB1 Monoclonal Antibody Does Not Affect Lupus Nephritis in MRL/lpr Mice

P. Limburg, M. Bijl, J. Westra, 2016, Molecular medicine.

University of Groningen Treatment with Anti-HMGB1 Monoclonal Antibody Does Not Affect Lupus Nephritis in MRL/lpr Mice

P. Limburg, M. Bijl, J. Westra, 2016 .

Treatment with anti-HMGB 1 monoclonal antibody does not affect lupus nephritis in MRL / lpr mice

M. Bijl, J. Westra, P. Heeringa, 2016 .

C-reactive protein levels during disease exacerbations and infections in systemic lupus erythematosus: a prospective longitudinal study.

P. Limburg, M. V. van Rijswijk, C. Kallenberg, 1990, The Journal of rheumatology.

Cloning and expression of murine CD27: comparison with 4‐1BB, another lymphocyte‐specific member of the nerve growth factor receptor family

B. Blom, W. Loenen, E. de Vries, 1993, European journal of immunology.

IgG antibody and TH1 immune responses to influenza vaccination negatively correlate with M-protein burden in monoclonal gammopathy of undetermined significance

H. Kluin-Nelemans, M. Bijl, J. Westra, 2013 .

Rituximab impairs immunoglobulin (Ig)M and IgG (subclass) responses after influenza vaccination in rheumatoid arthritis patients

M. Bijl, J. Westra, S. Assen, 2014, Clinical and experimental immunology.

Predominance of IgGl and IgG4 subclasses of anti‐neutrophil cytoplasmic autoantibodies (ANCA) in patients with Wegener's granulomatosis and clinically related disorders

P. Limburg, E. Brouwer, C. Kallenberg, 1991, Clinical and experimental immunology.

Clinical associations of antiribonucleoprotein antibodies in patients with systemic lupus erythematosus.

C. Kallenberg, P. Limburg, H. Groen, 1990, Seminars in arthritis and rheumatism.

Lack of IL-17 Receptor A signaling aggravates lymphoproliferation in C57BL/6 lpr mice

J. Westra, P. Heeringa, R. Hendriks, 2019, Scientific Reports.

Antibodies to skeletal muscle in myasthenia gravis Part 3. Relation with clinical course and therapy

P. Limburg, J. Kuks, H. Oosterhuis, 1993, Journal of the Neurological Sciences.

Antibodies to skeletal muscle in myasthenia gravis Part 1. diagnostic value for the detection of thymoma

P. Limburg, J. Kuks, H. Oosterhuis, 1993, Journal of the Neurological Sciences.

Effects of smoking on activation markers, Fas expression and apoptosis of peripheral blood lymphocytes

P. Limburg, M. Bijl, C. Kallenberg, 2001, European journal of clinical investigation.

Shifts of anti-Sm-specific antibodies in patients with systemic lupus erythematosus: analysis by counter-immunoelectrophoresis, immunoblotting and RNA-immunoprecipitation.

P. Limburg, C. Kallenberg, G. Horst, 1991, Journal of autoimmunity.

Serum amyloid P component binds to late apoptotic cells and mediates their uptake by monocyte-derived macrophages.

C. Kallenberg, P. Limburg, M. Bijl, 2003, Arthritis and rheumatism.

Antineutrophil cytoplasmic antibodies in primary sclerosing cholangitis: defined specificities may be associated with distinct clinical features.

P. Limburg, J. Kleibeuker, H. Peter, 1998, The American journal of medicine.

Catalase and alpha-enolase: two novel granulocyte autoantigens in inflammatory bowel disease (IBD).

P. Limburg, J. Kleibeuker, C. Kallenberg, 1998, Clinical and experimental immunology.

Impact of Aging on the Frequency, Phenotype, and Function of CD161-Expressing T Cells

B. Kroesen, A. Boots, E. Brouwer, 2018, Front. Immunol..

Does analysis of the antigenic specificities of anti-neutrophil cytoplasmic antibodies contribute to their clinical significance in the inflammatory bowel diseases?

P. Limburg, J. Kleibeuker, C. Kallenberg, 1999, Scandinavian journal of gastroenterology.

Antineutrophil cytoplasmic antibodies in systemic lupus erythematosus.

P. Limburg, H. Bootsma, P. Spronk, 1996, British journal of rheumatology.

Anti-neutrophil cytoplasmic antibodies (ANCA) ininflammatory bowel disease: characterization andclinical correlates

G. Horst, 1994 .

Antineutrophil cytoplasmic antibodies in rheumatoid arthritis. Characterization and clinical correlations.

M. V. van Leeuwen, P. Limburg, C. Kallenberg, 1993, Arthritis and rheumatism.

Titres of anti-neutrophil cytoplasmic antibodies in inflammatory bowel disease are not related to disease activity.

P. Limburg, J. Kleibeuker, C. Kallenberg, 1999, QJM : monthly journal of the Association of Physicians.

Autoantibodies to box A of high mobility group box 1 in systemic lupus erythematosus

P. Limburg, J. Westra, P. Heeringa, 2017, Clinical and experimental immunology.

Sequential development of antibodies to specific Sm polypeptides in a patient with systemic lupus erythematosus: evidence for independent regulation of anti-double-stranded DNA and anti-Sm antibody production.

P. Limburg, D. Jaarsma, C. Kallenberg, 1988, Arthritis and rheumatism.

Cell-mediated immune responses to inactivated trivalent influenza-vaccination are decreased in patients with common variable immunodeficiency.

C. Kallenberg, M. Bijl, J. Westra, 2011, Clinical immunology.

Altered Cellular and Humoral Immunity to Varicella‐Zoster Virus in Patients With Autoimmune Diseases

M. Bijl, J. Westra, C. Rondaan, 2014, Arthritis & rheumatology.

Expression of costimulatory molecules on peripheral blood lymphocytes of patients with systemic lupus erythematosus

P. Limburg, M. Bijl, C. Kallenberg, 2001, Annals of the rheumatic diseases.

Increased seroreactivity in tic disorder patients to a 60 kDa protein band from a neuronal cell line

J. Korf, C. Kallenberg, P. Hoekstra, 2003, Journal of Neuroimmunology.

Anti‐neutrophil cytoplasmic antibodies (ANCA) in inflammatory bowel disease: characterization and clinical correlates

C. Kallenberg, J. Broekroelofs, P C Limburg, 1994, Clinical and experimental immunology.

Lack of IL-17 Receptor A signaling aggravates lymphoproliferation in C57BL/6 lpr mice

J. Westra, P. Heeringa, R. Hendriks, 2019, Scientific Reports.

Quantifying Distribution of Flow Cytometric TCR-Vβ Usage with Economic Statistics

B. Kroesen, A. Boots, A. Buisman, 2015, PloS one.

Fas expression on peripheral blood lymphocytes in systemic lupus erythematosus (SLE): relation to lymphocyte activation and disease activity

P. Limburg, M. Bijl, C. Kallenberg, 2001, Lupus.

Reduced uptake of apoptotic cells by macrophages in systemic lupus erythematosus: correlates with decreased serum levels of complement

E. Reefman, M. Bijl, C. Kallenberg, 2005, Annals of the rheumatic diseases.

Anti‐dsDNA production coincides with concurrent B and T cell activation during development of active disease in systemic lupus erythematosus (SLE)

P. Limburg, B. V. D. van der Gun, C. Kallenberg, 1996, Clinical and experimental immunology.

Anti‐CD3‐induced and anti‐Fas‐induced apoptosis in systemic lupus erythematosus (SLE)

M. Bijl, C. Kallenberg, G. Horst, 2001, Clinical and experimental immunology.

Chapter VI Anti-CD 3-induced and anti-Fas-induced apoptosis in systemic lupus erythematosus ( SLE )

C. Kallenberg, P. Limburg, M. Bijl, 2001 .

Safety and efficacy of influenza vaccination in systemic lupus erythematosus patients with quiescent disease

M. Bijl, J. Wilschut, A. Huckriede, 2005, Annals of the rheumatic diseases.

Low-affinity TCR engagement drives IL-2-dependent post-thymic maintenance of naive CD4+ T cells in aged humans

B. Kroesen, I. Joosten, A. Boots, 2015, Aging cell.

Mycophenolate mofetil prevents a clinical relapse in patients with systemic lupus erythematosus at risk

P. Limburg, M. Bijl, H. Bootsma, 2003, Annals of the rheumatic diseases.

Levels of complement in sera from inactive SLE patients, although decreased, do not influence in vitro uptake of apoptotic cells.

M. Bijl, C. Kallenberg, G. Horst, 2005, Journal of autoimmunity.

B-CELL ACTIVATION CORRELATES WITH IG-LEVELS BUT NOT WITH ANTI-DSDNA IN NON-ACTIVE SLE, AND INCREASES PARALLEL TO ANTI-DSDNA PRIOR TO DISEASE-ACTIVITY

P. Spronk, C. Kallenberg, G. Horst, 1993 .

Prevalence and clinical significance of anti-lactoferrin autoantibodies in inflammatory bowel diseases and primary sclerosing cholangitis.

P. Limburg, J. Kleibeuker, C. Kallenberg, 1998, Advances in experimental medicine and biology.

Lupus Erythematosus ( SLE ) : relation to lymphocyte activation and disease activity

C. Kallenberg, P. Limburg, M. Bijl, 2001 .

Prevalence and characterization of neutrophil cytoplasmic antibodies in autoimmune liver diseases

C. Kallenberg, P. Limburg, J. Kleibeuker, 1993, Hepatology.

Antineutrophil antibodies in inflammatory bowel disease recognize different antigens.

P. Limburg, C. Kallenberg, J. Broekroelofs, 1993, Advances in experimental medicine and biology.

Neutrophil cytoplasmic autoantibodies after liver transplantation in patients with primary sclerosing cholangitis.

C. Kallenberg, A. Gouw, A. Mulder, 1993, Journal of hepatology.

Reduced uptake of apoptotic cells by macrophages in systemic lupus erythematosus: correlates with decreased serum levels of complement

C. Kallenberg, E. Reefman, P. Limburg, 2005, Annals of the rheumatic diseases.

Antibodies to skeletal muscle in myasthenia gravis Part 2. Prevalence in non-thymoma patients

P. Limburg, J. Kuks, H. Oosterhuis, 1993, Journal of the Neurological Sciences.

Catalase and α‐enolase: two novel granulocyte autoantigens in inflammatory bowel disease (IBD)

Zhao, Roozendaal, P. Limburg, 1998 .

Anti-neutrophil cytoplasmic antibodies (ANCA) in autoimmune liver disease.

C. Kallenberg, G. Horst, J. H. Kleibeuker, 1993, Advances in Experimental Medicine and Biology.